2023 Philadelphia Spatial Biology Roadshow
NanoString Technologies is returning to take over The Academy of Natural Sciences! We invite you to an afternoon filled with presentations and discussions all about the future of spatial biology. Join us at our free event and network with spatial biology experts in Philadelphia, Pennsylvania, at The Academy of Natural Sciences of Drexel University.
Highlights from our speakers:
- Joseph Beechem, PhD, from NanoString Technologies will discuss the future of spatial omics applications and NanoString Technologies’ latest innovations.
- Charlly Kao, PhD, will share research on the CLEC16A locus in the human genome that has been strongly associated with a wide variety of autoimmune diseases and the use of spatial profiling to better understand the underlying etiology and driver pathways.
- Alli Wakefield will highlight Leica Biosystems as your partner in designing optimized, standardized, and automated histopathology workflows in spatial and translational research.
- Robert Yamulla, PhD, from Illumina will highlight how spatial sequencing is revolutionizing cancer research.
- Donald J. Nelson, PhD, from Azenta Life Sciences will present a case study of spatial profiling of a tissue microarray containing 60 urothelial carcinoma specimens using the GeoMx Digital Spatial Profiler.
Guest speakers will share their results and discoveries obtained using GeoMx Digital Spatial Profiler and CosMx Spatial Molecular Imager. The event will conclude with a networking reception in the Dinosaur Hall.
Agenda
2:00-4:30 p.m. Presentations in the Auditorium
4:30-6:00 p.m. Reception in the Dinosaur Hall
Presenters
Joseph Beechem, PhD, Chief Scientific Officer and Senior Vice President of Research and Development, NanoString Technologies
“Spatial-omics Revolution: Innovation Roadmap and Key Applications”
Charlly Kao, PhD, Senior Translational Scientist, Center for Applied Genomics at Children’s Hospital of Philadelphia
“Using Spatial Transcriptome Profiling to Elucidate New Targets and Pathways in Clec16A Knockout Mouse Model and in Kaposiform Hemangioendothelioma (KHE) Patients”
Alli Wakefield, Life Science Sales Specialist, Leica Biosystems
“Partnering Innovation with Automation: BOND RX research staining instrument provides superior quality and flexibility”
Robert Yamulla, PhD, Senior Marketing Manager, AMR Cancer Research, Illumina
“Spatial sequencing is revolutionizing cancer research”
Donald J. Nelsen, PhD, Technical Applications Scientist, Next Generation Sequencing, Azenta Life Sciences
“Spatial Genomics for Transcriptional and Proteomic Profiling”
Expertise on site
Matt Kane, Regional Account Manager, NanoString Technologies
Sayani Bhattacharjee, PhD, Field Application Scientist, NanoString Technologies
Amy Wahba, PhD, Senior Technical Sales Specialist, NanoString Technologies
Nicole Robinson, Field Applications Specialist, Leica Biosystems
Chelsea O’Brien, Senior Sequencing Specialist, Illumina
Christina Haydu, Account Manager, Pennsylvania – Genomic Services, Azenta Life Sciences
Directions to the venue
Thanks for attending!
Registration is now closed for this event.
Speakers
Joseph Beechem, PhD
Chief Scientific Officer and Senior Vice President of Research and Development, NanoString
Joseph M. Beechem, PhD, has served as the chief scientific officer and senior vice president of Research and Development at NanoString Technologies since April 2012. He has authored more than 200 peer-reviewed papers, averaging more than four citations each day, in diverse fields such as cancer immunology, infectious disease, imaging, biomathematics, physics, chemistry, spectroscopy, and diagnostics. In addition, Joseph Beechem is named on nearly 50 US patents or patent applications and has served on several editorial and scientific advisory boards. Joseph Beechem received a BS in Chemistry and Biology from Northern Kentucky University and a PhD in Biophysics from Johns Hopkins University.
Charlly Kao, PhD
Senior Translational Scientist, Center for Applied Genomics at Children's Hospital of Philadelphia
Charlly Kao, PhD, studied immunology at the University of Minnesota for his PhD and then did his post-doctoral work focusing on T cell adaptive responses to viral infections at the Wistar Institute and University of Pennsylvania. Afterwards, he began work at the Center for Applied Genomics (CAG) at the Children’s Hospital of Philadelphia (CHOP) as a staff scientist to manage translational projects and evaluating new omics technologies. He is also one of the co-founders of two biotech start-ups, NeuroFix Therapeutics and Arctic Therapeutics, that is/was commercializing/translating new technologies and therapies discovered by the CAG.
Alli Wakefield
Life Science Sales Specialist, Leica Biosystems
Alli Wakefield obtained her BS in Biology from Purdue University and has over seven years of sales experience in the life science field. In her current role, Alli is a life science sales specialist at Leica Biosystems, focused on helping customers with their digital pathology and advanced staining workflows. She covers the Mid-Atlantic region from Pennsylvania to South Carolina.
Robert Yamulla, PhD
Senior Marketing Manager, AMR Cancer Research, Illumina
Robert Yamulla, PhD, leads Illumina’s cancer research marketing strategy for North and South America. He is a cancer biologist specializing in next-generation sequencing, CRISPR/Cas9, and in vitro disease modeling. Robert received his PhD from Cornell University. His most recent research focused on identifying fundamental initiation mechanisms and causative factors for ovarian carcinoma. He has also developed mechanistic models of colon cancer progression as a Howard Hughes Medical Institute research fellow and studied rare genetic diseases with the Clinic for Special Children in Lancaster, Pennsylvania.
Donald J. Nelsen, PhD
Technical Applications Scientist, Next Generation Sequencing, Azenta Life Sciences
Donald J. Nelsen, PhD, is a Technical Applications Scientist for the Next-Generation Sequencing (NGS) team at Azenta Life Sciences. He received his PhD in Biology from the University of Arkansas in 2017. Joining the Azenta team in 2021, he brings experience in the broad usage of NGS platforms and data: from microbial identification to clinical diagnostics, to the manufacturing and testing of next-generation cell and gene therapies. As a member of the NGS team at Azenta, Donald provides consultative and project design support for researchers and investigators with interest in genomics, transcriptomics, and proteomics solutions.
